Fig. 4
Association between tumour immune microenvironment and progression-free survival with imatinib. a TIM-3+ CD3+; b CD204+ CD68+
Fig. 4 | British Journal of Cancer
Association between tumour immune microenvironment and progression-free survival with imatinib. a TIM-3+ CD3+; b CD204+ CD68+
